ASH Conference 2021: Graft-vs-Host Disease Treatment Advances
Doris M. Ponce, MD, a hematologic oncologist from Memorial Sloan Kettering Cancer Center (MSKCC) in New York, provided insight into and key takeaways from research on graft-vs-host disease (GVHD) presented at the meeting.
